No Recurrence of VTE 1 Year after COVID-19-Associated VTE Event
A study was conducted to determine outcomes in hospitalized patients with COVID-19 and VTE, during anticoagulation therapy and at 1-year follow-up.
A study was conducted to determine outcomes in hospitalized patients with COVID-19 and VTE, during anticoagulation therapy and at 1-year follow-up.
Researchers examined the relationship between multiple factors related to heart failure and worse outcomes in patients hospitalized for pneumonia.
A team of researchers analyzed the virologic response of hepatitis C virus to direct-acting antivirals in patients with HIV.
This study looked at adults residing in 15 countries who were invited to participate every 2 weeks in an online survey.
Presenting at DDW 2022, researchers evaluated data from the PRISM3 placebo-controlled trial and the PRISM-EXT open-label extension trial of CP101, an investigational microbiome therapeutic.
Participants of the Adolescent Social Development and Sleep study which recruited patients in Texas between 2019 and 2020 before local quarantine restrictions were asked to participate in this study about COVID-19 behaviors and opinions.
Investigators at the San Francisco Veterans Affairs (VA) Health Care System evaluated VA health records between February 2020 and November 2021.
A study was conducted to determine the relationship between ambient particulate matter and 30-day readmission risk for heart failure patients.
Investigators assessed the impact of treatment with empagliflozin on patients with type 2 diabetes and chronic obstructive pulmonary disease.
The aim of the study was to evaluate the prevalence of chronic pain disparities among the major racial and ethnic groups in the US.